{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:24:09Z","timestamp":1791339849827,"version":"4.3.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.yebeh.2020.107612","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T21:36:04Z","timestamp":1606167364000},"page":"107612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"PA","title":["Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-8717","authenticated-orcid":false,"given":"Debopam","family":"Samanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10072-017-3188-y","article-title":"Lennox-Gastaut syndrome: a comprehensive review","volume":"39","author":"Asadi-Pooya","year":"2018","journal-title":"Neurol Sci"},{"issue":"Suppl 5","key":"10.1016\/j.yebeh.2020.107612_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.03177.x","article-title":"Definition and natural history of lennox-gastaut syndrome","volume":"52","author":"Camfield","year":"2011","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox-gastaut syndrome: A consensus approach on diagnosis, assessment, management, and trial methodology","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107612_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/CPJ.0000000000000527","article-title":"Late-onset Lennox-Gastaut syndrome: Diagnostic evaluation and outcome","volume":"8","author":"Smith","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107612_b0025","first-page":"401","article-title":"Lennox-Gastaut syndrome in the adult","volume":"143","author":"Roger","year":"1987","journal-title":"Rev Neurol"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2020.107612_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2013.01.009","article-title":"Copy number variants in adult patients with lennox-gastaut syndrome features","volume":"105","author":"Lund","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107612_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.seizure.2017.11.009","article-title":"The epilepsy phenotype in adult patients with intellectual disability and pathogenic copy number variants","volume":"53","author":"d'Orsi","year":"2017","journal-title":"Seizure"},{"issue":"19","key":"10.1016\/j.yebeh.2020.107612_b0040","first-page":"713","article-title":"Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome","volume":"108","author":"Vassella","year":"1978","journal-title":"Schweizerische medizinische Wochenschrift"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107612_b0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1982.tb05085.x","article-title":"Sodium valproate: monotherapy and polytherapy","volume":"23","author":"Covanis","year":"1982","journal-title":"Epilepsia"},{"issue":"25","key":"10.1016\/j.yebeh.2020.107612_b0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/j.1950-6945.2001.tb00387.x","article-title":"Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG","volume":"3","author":"Bisulli","year":"2001","journal-title":"Epileptic Disord"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107612_b0060","first-page":"1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Topiramate YL Study Group Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2020.107612_b0065","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1111\/j.1528-1157.2000.tb02179.x","article-title":"Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial","volume":"41","author":"Glauser","year":"2000","journal-title":"Topiramate YL Study Group Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107612_b0070","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/WNL.52.8.1540","article-title":"Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"52","author":"French","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"10.1016\/j.yebeh.2020.107612_b0080","first-page":"S18","article-title":"Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial","volume":"34","author":"Dodson","year":"1993","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.braindev.2007.09.004","article-title":"Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience","volume":"30","author":"You","year":"2008","journal-title":"Brain Dev"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107612_b0090","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1528-1167.2008.01935.x","article-title":"Clobazam in the treatment of Lennox-Gastaut syndrome","volume":"50","author":"Conry","year":"2009","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.yebeh.2020.107612_b0095","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yebeh.2012.09.039","article-title":"Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study","volume":"25","author":"Ng","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"17","key":"10.1016\/j.yebeh.2020.107612_b0105","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.0000000000003253","article-title":"Deconstructing tolerance with clobazam: Post-hoc analyses from an open-label extension study","volume":"87","author":"Gidal","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107612_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yebeh.2017.10.003","article-title":"Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome","volume":"78","author":"Isojarvi","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0115","article-title":"Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome","volume":"5","author":"Francois","year":"2017","journal-title":"J Mark Access Health Policy"},{"key":"10.1016\/j.yebeh.2020.107612_b0120","first-page":"1","article-title":"An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome","volume":"2","author":"Besag","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"21","key":"10.1016\/j.yebeh.2020.107612_b0125","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.2010.01334.x","article-title":"Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study","volume":"122","author":"Kluger","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107612_b0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107612_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.01.002","article-title":"Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial","volume":"121","author":"Ohtsuka","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107612_b0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.seizure.2017.02.008","article-title":"Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data","volume":"47","author":"Kothare","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107612_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yebeh.2017.08.026","article-title":"Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study","volume":"76","author":"Nikanorova","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2015.02.003","article-title":"Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome","volume":"112","author":"Kessler","year":"2015","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40120-016-0041-9","article-title":"Treatment of adults with lennox-gastaut syndrome: further analysis of efficacy and safety\/tolerability of rufinamide","volume":"5","author":"McMurray","year":"2016","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107612_b0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/epi4.12314","article-title":"Novel seizure outcomes in patients with Lennox-Gastaut syndrome: Post-hoc analysis of seizure-free days in rufinamide Study 303","volume":"4","author":"Auvin","year":"2019","journal-title":"Epilepsia Open"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"10125","key":"10.1016\/j.yebeh.2020.107612_b0175","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"20","key":"10.1016\/j.yebeh.2020.107612_b0180","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107612_b0185","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40263-018-0558-9","article-title":"Efficacy and safety of adjunctive cannabidiol in patients with Lennox-Gastaut Syndrome: a systematic review and meta-analysis","volume":"32","author":"Lattanzi","year":"2018","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107612_b0190","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107612_b0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2019.03.015","article-title":"Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: expanded access program results","volume":"154","author":"Laux","year":"2019","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.pediatrneurol.2014.06.004","article-title":"Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome","volume":"51","author":"Kim","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107612_b0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2017.05.036","article-title":"Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome","volume":"74","author":"Auvin","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0210","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.yebeh.2010.09.024","article-title":"Does lacosamide aggravate Lennox-Gastaut syndrome? Report on three consecutive cases","volume":"19","author":"Cuzzola","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107612_b0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ane.12221","article-title":"Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome","volume":"129","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2020.107612_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2015.10.009","article-title":"Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox-Gastaut syndrome: An observational study","volume":"33","author":"Andrade-Machado","year":"2015","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107612_b0225","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/epi.14540","article-title":"A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome","volume":"59","author":"Lagae","year":"2018","journal-title":"Epilepsia"},{"issue":"18","key":"10.1016\/j.yebeh.2020.107612_b0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.0000000000006432","article-title":"Lorcaserin therapy for severe epilepsy of childhood onset: A case series","volume":"91","author":"Tolete","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107612_b0235","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1469-8749.2012.04233.x","article-title":"Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature","volume":"54","author":"Lemmon","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3988\/jcn.2015.11.1.26","article-title":"Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis","volume":"11","author":"Ye","year":"2015","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"10.1016\/j.yebeh.2020.107612_b0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yebeh.2016.02.038","article-title":"Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges","volume":"58","author":"Cervenka","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0250","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1528-1167.2008.01940.x","article-title":"Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction","volume":"50","author":"Shahwan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107612_b0255","first-page":"755","article-title":"Vagus nerve stimulation in the treatment of patients with pharmacoresistant epilepsy: our experiences","volume":"35","author":"Hajnsek","year":"2011","journal-title":"Coll Antropol"},{"key":"10.1016\/j.yebeh.2020.107612_b0260","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852900001516","article-title":"Vagus nerve stimulation and Lennox-Gastaut syndrome: a review of the literature and data from the VNS patient registry","volume":"6","author":"Karceski","year":"2001","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2020.107612_b0265","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1046\/j.1528-1157.2001.23900.x","article-title":"Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome","volume":"42","author":"Frost","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107612_b0270","doi-asserted-by":"crossref","DOI":"10.1684\/epd.2011.0479","article-title":"Vagus nervestimulation: effectiveness and tolerability in 64 pAEDiatric patients withrefractory epilepsies","volume":"13","author":"Cersosimo","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2020.107612_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/S1525-5050(02)00517-6","article-title":"Long-term effects of 24-month treatment with vagus nerve stimulation on behaviour inchildren with Lennox-Gastaut syndrome","volume":"3","author":"Aldenkamp","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0280","doi-asserted-by":"crossref","DOI":"10.1097\/00004691-200109000-00006","article-title":"Vagus nervestimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychologicaleffects, and cost-effectiveness","volume":"18","author":"Majoie","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107612_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2009.07.038","article-title":"Long-term vagus nerve stimulation in the treatment of Lennox-Gastaut syndrome","volume":"16","author":"Kostov","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0290","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.seizure.2006.06.001","article-title":"Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients","volume":"15","author":"Rychlicki","year":"2006","journal-title":"Seizure"},{"issue":"Suppl 4","key":"10.1016\/j.yebeh.2020.107612_b0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/epi.12742","article-title":"Surgical options for patients with Lennox-Gastaut syndrome","volume":"55","author":"Douglass","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107612_b0300","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/614263","article-title":"Surgical treatment of patients with Lennox-Gastaut syndrome phenotype","volume":"2012","author":"Liu","year":"2012","journal-title":"Sci World J"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0305","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1542\/peds.2009-0566","article-title":"Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome","volume":"125","author":"Lee","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000266386.55715.3f","article-title":"Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings","volume":"69","author":"Wyllie","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107612_b0315","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1528-1167.2006.00430.x","article-title":"Extended, one-stage callosal section for treatment of refractory secondarily generalized epilepsy in patients with Lennox-Gastaut and Lennox-like syndromes","volume":"47","author":"Cukiert","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107612_b0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s003810050018","article-title":"Seizure outcome after corpus callosotomy: the Taiwan experience","volume":"16","author":"Kwan","year":"2000","journal-title":"Childs Nerv Syst"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107612_b0325","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1528-1167.2006.00592.x","article-title":"Efficacy and safety of radiosurgical callosotomy: a retrospective analysis","volume":"47","author":"Feichtinger","year":"2006","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107612_b0330","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fneur.2017.00505","article-title":"Expert opinion on the management of Lennox-Gastaut syndrome: treatment algorithms and practical considerations","volume":"29","author":"Cross","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2020.107612_b0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2018.12.015","article-title":"How can transition to adult care be best orchestrated for adolescents with epilepsy","volume":"93","author":"Camfield","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"Suppl 5","key":"10.1016\/j.yebeh.2020.107612_b0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1528-1167.2011.03179.x","article-title":"Strategies for transitioning to adult care for youth with Lennox-Gastaut syndrome and related disorders","volume":"52","author":"Camfield","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2020.107612_b0345","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1157.1996.tb01820.x","article-title":"Long-term prognosis of Lennox-Gastaut syndrome","volume":"37","author":"Oguni","year":"1996","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2020.107612_b0350","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1528-1157.1996.tb01821.x","article-title":"Evolution of Lennox-Gastaut syndrome: a long-term longitudinal study","volume":"37","author":"Yagi","year":"1996","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.yebeh.2020.107612_b0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eplepsyres.2010.01.012","article-title":"Lennox-Gastaut syndrome in adulthood: clinical and EEG features","volume":"89","author":"Ferlazzo","year":"2010","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107612_b0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0883073809348355","article-title":"Increased risk of death among children with Lennox-Gastaut syndrome and infantile spAEDs","volume":"25","author":"Autry","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107612_b0365","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/JMDH.S69300","article-title":"Lennox-Gastaut syndrome: impact on the caregivers and families of patients","volume":"7","author":"Gibson","year":"2014","journal-title":"J Multidisc Healthc"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107612_b0370","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.seizure.2009.06.005","article-title":"Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: literature review","volume":"18","author":"Gallop","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107612_b0375","unstructured":"Accessed. https:\/\/www.lgsfoundation.org\/adultsandlgs."},{"issue":"1","key":"10.1016\/j.yebeh.2020.107612_b0380","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1684\/epd.2016.0793","article-title":"Nocturnal interictal epileptic discharges in adult Lennox-Gastaut syndrome: the effect of sleep stage and time of night","volume":"18","author":"Sforza","year":"2016","journal-title":"Epileptic Disord"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0385","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-1211(01)00280-7","article-title":"Sleep in Lennox-Gastaut syndrome: the role of the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes","volume":"46","author":"Eisensehr","year":"2001","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107612_b0390","first-page":"127","article-title":"Women with epilepsy: clinically relevant issues","volume":"31","author":"Bangar","year":"2016","journal-title":"Funct Neurol"},{"issue":"15\u201316","key":"10.1016\/j.yebeh.2020.107612_b0395","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1365-2702.2009.03174.x","article-title":"Review of risk factors and preventative strategies for fall-related injuries in people with intellectual disabilities","volume":"19","author":"Willgoss","year":"2010","journal-title":"J Clin Nurs"},{"issue":"17","key":"10.1016\/j.yebeh.2020.107612_b0400","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.0000000000003685","article-title":"Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"88","author":"Harden","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107612_b0405","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yebeh.2018.06.040","article-title":"SUDEP and seizure safety communication: Assessing if people hear and act","volume":"86","author":"Young","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0410","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yebeh.2017.05.021","article-title":"Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome","volume":"73","author":"Pi\u00f1a-Garza","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0415","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yebeh.2018.08.032","article-title":"Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study","volume":"88","author":"Reaven","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107612_b0420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yebeh.2018.11.016","article-title":"The refractory epilepsy screening tool for Lennox-Gastaut syndrome (REST-LGS)","volume":"90","author":"Pina-Garza","year":"2019","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:39:34Z","timestamp":1761503974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020307927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":84,"alternative-id":["S1525505020307927"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107612","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107612"}}